DavidKWebbMD

PubMed

• Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.
  Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter J> ;Blood. 2011-10-27
• Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.
  Coenen EA, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Hee...> ;Blood. 2011-06-30
• Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
  Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, ...> ;Blood. 2009-09-17
• Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.
  Howe, S.J., Mansour, M.R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M.H., Pike-Overzet, K., Chatters, S.J., de Ridder, D., Gilmour, K.C.,...> ;J Clin Invest. 2008 Sep
• Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
  Norton, A., Fisher, C., Liu, H., Wen, Q., Mundschau, G., Fuster, J.L., Hasle, H., Zeller, B., Webb, D.K., O'Marcaigh, A., Sorrell, A., Hilden, J., Gamis, A., Crispino,...> ;Blood. 2007 Aug 1
• Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.
  Hasle, H., Alonzo, T.A., Auvrignon, A., Behar, C., Chang, M., Creutzig, U., Fischer, A., Forestier, E., Fynn, A., Haas, O.A., Harbott, J., Harrison, C.J., Heerema, N.A...> ;Blood. 2007 Jun 1
• Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.
  Cooper N, Rao K, Gilmour K, Hadad L, Adams S, Cale C, Davies G, Webb D, Veys P, Amrolia P> ;Blood. 2006-02-01
• Body composition in children in remission from acute lymphoblastic leukemia.
  Murphy, A.J., Wells, J.K., Williams, J.E., Fewtrell, M.S., Davies, P.W., Webb, D.K.> ;Am J Clin Nutr. 2006 Jan
• Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion.
  Worth A, Rao K, Webb D, Chessells J, Passmore J, Veys P> ;Blood. 2003-03-01
• Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.
  Henter J, Samuelsson-Horne A, Aricò M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G> ;Blood. 2002-10-01
• Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute my...
  Webb DK, Harrison G, Stevens RF, Gibson BG, Hann IM, Wheatley K> ;Blood. 2001-09-15
• Nonmyeloablative stem cell transplantation for congenital immunodeficiencies.
  Amrolia P, Gaspar HB, Hassan A, Webb D, Jones A, Sturt N, Mieli-Vergani G, Pagliuca A, Mufti G, Hadzic N, Davies G, Veys P> ;Blood. 2000-08-15
• Effect of long-term olive oil dietary intervention on postprandial triacylglycerol and factor VII metabolism.
  Roche HM, Zampelas A, Knapper JM, Webb D, Brooks C, Jackson KG, Wright JW, Gould BJ, Kafatos A, Gibney MJ, Williams CM> ;Am. J. Clin. Nutr.. 1998-09-01
• Optimizing therapy for myeloid disorders of Down syndrome.
  Webb, D. K.> ;Br J Haematol. 2005 Oct
• Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia.
  Morris, E. C., Harrison, G., Bailey, C. C., Hann, I. M., Hill, F. G., Gibson, B. E., Richards, S., Webb, D. K.> ;Br J Haematol. 2003 Mar
• Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.
  Webb, D. K., Passmore, S. J., Hann, I. M., Harrison, G., Wheatley, K., Chessells, J. M.> ;Br J Haematol. 2002 Apr
• Body composition of long-term survivors of acute lymphoblastic leukaemia.
  Warner, J. T., Evans, W. D., Webb, D. K., Gregory, J. W.> ;Med Pediatr Oncol. 2002 Mar
• Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial.
  Gibson, B. E., Webb, D. K., Howman, A. J., De Graaf, S. S., Harrison, C. J., Wheatley, K.> ;Br J Haematol. 2011 Nov
• Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United ...
  Temming, P., Qureshi, A., Hardt, J., Leiper, A. D., Levitt, G., Ancliff, P. J., Webb, D. K.> ;Pediatr Blood Cancer. 2011 Apr
• Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.
  Harrison, C. J., Hills, R. K., Moorman, A. V., Grimwade, D. J., Hann, I., Webb, D. K., Wheatley, K., de Graaf, S. S., van den Berg, E., Burnett, A. K., Gibson, B. E.> ;J Clin Oncol. 2010 Jun 1
• Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.
  Rao, A., Hills, R. K., Stiller, C., Gibson, B. E., de Graaf, S. S., Hann, I. M., O'Marcaigh, A., Wheatley, K., Webb, D. K.> ;Br J Haematol. 2006 Mar
• Join now to see all